Generex Biotechnology Corporation Stock OTC Bulletin Board
Equities
US3714851033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Jan. 19 | Motion for Asset Sale Approved for Generex Biotechnology Corporation | CI |
2023 | Motion for Asset Sale Filed by Generex Biotechnology Corporation | CI |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 17-11-20 |
Mark Carrao
DFI | Director of Finance/CFO | - | 16-12-31 |
Terry Thompson
COO | Chief Operating Officer | 65 | 18-06-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 04-02-29 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 04-12-31 |
Craig Eagle
BRD | Director/Board Member | 57 | 17-11-20 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |